Pfizer Inc. recalls 2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector
Recalled November 15, 2023 · FDA recall D-0102-2024 · Pfizer
Hazard
Presence of Particulate Matter: identified as glass. · FDA Class I
Units
3,200 vials
Sold at
Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.
Description
Presence of Particulate Matter: identified as glass.
Product
2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4903-11
Manufacturer(s)
Pfizer Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →